BioSpace News Archive

XNK Therapeutics AB announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer, effective immediately.

Immunovia announced it is realigning its Swedish operations with its strategic priorities to drive R&D productivity and focus on the US commercialization of the IMMray™ PanCan-d test.

PinCell, a biotechnology company developing a first-in-class therapy for rare and debilitating autoimmune skin blistering diseases, has announced the generation of a transgenic mouse model that will provide an effective in-vivo platform for the development of its lead candidate.

VectorY Therapeutics and Annogen announced a research collaboration for the identification of CNS-cell specific synthetic promoters for use in VectorY’s vectorized antibody programs.

Prenetics Global Limited a leader in genomic and diagnostic testing, announced an executive leadership change to ensure the company realizes the full potential of its broad genetics and digital testing platform and as a commitment to the EMEA market.

Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Food and Drug Administration 510 clearance for the Flex-Thread™ Ulna Intramedullary Nail System.

Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, announced the appointment of Kristof Van Emelen, PhD, as Vice President of Drug Discovery.

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has submitted a Clinical Trial Application for a planned Phase-1 clinical trial for LUCID-MS, a candidate for the treatment of Multiple Sclerosis.

Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have received Wharton’s Jelly applications to the refractory sacroiliac (SI) joint to mitigate loss of function and pain, improving quality of life.

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new data generated by the CosMx™ Spatial Molecular Imager (SMI).